Ocular Therapeutix: 3Q Earnings Snapshot
BEDFORD, Mass. (AP) _ Ocular Therapeutix Inc. (OCUL) on Wednesday reported a loss of $15 million in its third quarter.
The Bedford, Massachusetts-based company said it had a loss of 38 cents per share.
The biotechnology company posted revenue of $498,000 in the period.
Ocular Therapeutix shares have increased 22 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $5.41, a drop of almost 6 percent in the last 12 months.